Medical research

Human organ chips enable COVID-19 drug repurposing

A Wyss Institute-led collaboration spanning four research labs and hundreds of miles has used the Institute's organ-on-a-chip (Organ Chip) technology to identify the antimalarial drug amodiaquine as a potent inhibitor of ...

Neuroscience

Flicker stimulation shines in clinical trial for epilepsy

Biomedical engineer Annabelle Singer has spent the past decade developing a noninvasive therapy for Alzheimer's disease that uses flickering lights and rhythmic tones to modulate brain waves. Now she has discovered that the ...

Alzheimer's disease & dementia

Human neuron model paves the way for new Alzheimer's therapies

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer's disease ...

page 1 from 40